一品红：子公司获得左氧氟沙星口服溶液注册证书

Core Viewpoint - The company Yipinhong (300723) has received approval from the National Medical Products Administration for the drug registration certificate of levofloxacin oral solution, indicating a significant advancement in its product offerings [1] Company Summary - Yipinhong's wholly-owned subsidiary, Guangzhou Yipinhong Pharmaceutical Co., Ltd., has been granted the drug registration certificate for levofloxacin oral solution [1] - The levofloxacin oral solution is indicated for the treatment of mild, moderate, and severe infections caused by sensitive strains of bacteria such as Staphylococcus aureus, Pseudomonas aeruginosa, Klebsiella pneumoniae, and others in adults aged 18 and above [1]